40. Goulaouic H, Roulon T, Flamand O, Grondard L, Lavelle F, et al. (1999) Purification and characterization of human DNA topoisomerase IIIalpha. Nucleic Acids Res 27: 2443–2450. 41. Douarre C, Gomez D, Morjani H, Zahm JM, O’Donohue M F, et al. (2005) Overexpression of Bcl-2 is associated with apoptotic resistance to the G- quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence. Nucleic Acids Res 33: 2192–2203. 42. Gomez D, O’Donohue MF, Wenner T, Douarre C, Macadre J, et al. (2006) The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. Cancer Res 66: 6908–6912. 43. Lemarteleur T, Gomez D, Paterski R, Mandine E, Mailliet P, et al. (2004) Stabilization of the c-myc gene promoter quadruplex by specific ligands inhibitors of telomerase. Biochem Biophys Res Commun 323: 802–808. 44. Gomez D, Paterski R, Lemarteleur T, Shin-Ya K, Mergny JL, et al. (2004) Interaction of telomestatin with the telomeric single-strand overhang. J Biol Chem 279: 41487–41494. 45. Ambrus A, Chen D, Dai J, Bialis T, Jones RA, et al. (2006) Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution. Nucleic Acids Res 34: 2723–2735. 46. Brassart B, Gomez D, De Cian A, Paterski R, Montagnac A, et al. (2007) A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells. Mol Pharmacol 72: 631–640. 47. Rodriguez R, Muller S, Yeoman JA, Trentesaux C, Riou JF, et al. (2008) A Novel Small Molecule That Alters Shelterin Integrity and Triggers a DNA- Damage Response at Telomeres. J Am Chem Soc. 48. Tahara H, Shin-Ya K, Seimiya H, Yamada H, Tsuruo T, et al. (2006) G- Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 39 telomeric overhang in cancer cells. Oncogene 25: 1955–1966. Telomestatin Uncaps Telomeres 49. Gomez D, Wenner T, Brassart B, Douarre C, O’Donohue MF, et al. (2006) Telomestatin-induced telomere uncapping is modulated by POT1 through G- overhang extension in HT1080 human tumor cells. J Biol Chem 281: 38721–38729. 50. Wu L, Davies SL, North PS, Goulaouic H, Riou JF, et al. (2000) The Bloom’s syndrome gene product interacts with topoisomerase III. J Biol Chem 275: 9636–9644. 51. d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, et al. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194–198. 52. Kim MY, Gleason-Guzman M, Izbicka E, Nishioka D, Hurley LH (2003) The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. Cancer Res 63: 3247–3256. 53. Wu Y, Shin-ya K, Brosh RM, Jr. (2008) FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol Cell Biol 28: 4116–4128. 54. Zhong ZH, Jiang WQ, Cesare AJ, Neumann AA, Wadhwa R, et al. (2007) Disruption of telomere maintenance by depletion of the MRE11/RAD50/ NBS1 complex in cells that use alternative lengthening of telomeres. J Biol Chem 282: 29314–29322. 55. Jiang WQ, Zhong ZH, Henson JD, Reddel RR (2007) Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene. 56. Draskovic I, Arnoult N, Steiner V, Bacchetti S, Lomonte P, et al. (2009) Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination. Proc Natl Acad Sci U S A in press. 57. Fouche N, Cesare AJ, Willcox S, Ozgur S, Compton SA, et al. (2006) The basic domain of TRF2 directs binding to DNA junctions irrespective of the presence of TTAGGG repeats. J Biol Chem 281: 37486–37495. PLoS ONE | www.plosone.org 14 September 2009 | Volume 4 | Issue 9 | e6919